Page last updated: 2024-10-19

phosphorylcholine and Pneumococcal Infections

phosphorylcholine has been researched along with Pneumococcal Infections in 44 studies

Phosphorylcholine: Calcium and magnesium salts used therapeutically in hepatobiliary dysfunction.
phosphocholine : The phosphate of choline; and the parent compound of the phosphocholine family.

Pneumococcal Infections: Infections with bacteria of the species STREPTOCOCCUS PNEUMONIAE.

Research Excerpts

ExcerptRelevanceReference
"Aging in mice is accompanied by qualitative changes in the antibody repertoire to phosphorylcholine (PC), a natural epitope of certain pneumococci."3.68Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. ( Cerny, J; Nicoletti, C; Yang, X, 1993)
"Phosphorylcholine (PC) is an immunodominant epitope in some pathogens including Streptococcus pneumoniae and it is well-known that PC-specific antibodies (Abs) play a key role in the induction of protective immunity against pneumococcal infection."1.37Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination. ( Baatarjav, T; Fujihashi, K; Fukui, M; Gilbert, RS; Goto, M; Ito, HO; Kataoka, K; Kawabata, S; Terao, Y; Yamamoto, M, 2011)

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199010 (22.73)18.7374
1990's10 (22.73)18.2507
2000's8 (18.18)29.6817
2010's15 (34.09)24.3611
2020's1 (2.27)2.80

Authors

AuthorsStudies
Ohori, J1
Iuchi, H1
Maseda, Y1
Kurono, Y1
Kataoka, K2
Fukuyama, Y1
Briles, DE11
Miyake, T1
Fujihashi, K2
Ngwa, DN1
Agrawal, A3
Vale, AM1
Kapoor, P1
Skibinski, GA1
Elgavish, A1
Mahmoud, TI1
Zemlin, C1
Zemlin, M1
Burrows, PD1
Nobrega, A1
Kearney, JF1
Schroeder, HW1
Young, NM1
Foote, SJ1
Wakarchuk, WW1
Zeng, XF1
Ma, Y1
Yang, L1
Zhou, L1
Xin, Y1
Chang, L1
Zhang, JR1
Hao, X1
Vassal-Stermann, E1
Lacroix, M1
Gout, E1
Laffly, E1
Pedersen, CM1
Martin, L1
Amoroso, A1
Schmidt, RR1
Zähringer, U1
Gaboriaud, C1
Di Guilmi, AM1
Thielens, NM1
Ramos-Sevillano, E1
Urzainqui, A1
Campuzano, S1
Moscoso, M1
González-Camacho, F1
Domenech, M1
Rodríguez de Córdoba, S1
Sánchez-Madrid, F1
Brown, JS1
García, E1
Yuste, J1
Chuang, YP1
Peng, ZR1
Tseng, SF1
Lin, YC1
Sytwu, HK1
Hsieh, YC1
Gang, TB2
Hanley, GA1
Zamora-Carreras, H1
Maestro, B1
Strandberg, E1
Ulrich, AS1
Sanz, JM1
Jiménez, MÁ1
Hergott, CB1
Roche, AM1
Naidu, NA1
Mesaros, C1
Blair, IA1
Weiser, JN2
Gutiérrez-Fernández, J1
Saleh, M1
Alcorlo, M1
Gómez-Mejía, A1
Pantoja-Uceda, D1
Treviño, MA1
Voß, F1
Abdullah, MR1
Galán-Bartual, S1
Seinen, J1
Sánchez-Murcia, PA1
Gago, F1
Bruix, M1
Hammerschmidt, S1
Hermoso, JA1
Thornton, JA1
Durick-Eder, K1
Tuomanen, EI3
Baatarjav, T1
Gilbert, RS1
Terao, Y1
Fukui, M1
Goto, M1
Kawabata, S1
Yamamoto, M1
Ito, HO1
Hammond, DJ1
Singh, SK1
Ferguson, DA1
Mishra, VK1
Harris, SL2
Dagtas, AS1
Diamond, B4
Koppel, EA1
Wieland, CW1
van den Berg, VC1
Litjens, M1
Florquin, S1
van Kooyk, Y1
van der Poll, T1
Geijtenbeek, TB1
Daniels, CC1
Briles, TC1
Mirza, S1
Håkansson, AP1
Fillon, S1
Soulis, K1
Rajasekaran, S1
Benedict-Hamilton, H1
Radin, JN1
Orihuela, CJ1
El Kasmi, KC1
Murti, G1
Kaushal, D1
Gaber, MW1
Weber, JR1
Murray, PJ1
Forman, C6
Hudak, S3
Claflin, JL4
McDaniel, LS1
Benjamin, WH1
McNamara, MK1
Ward, RE1
Kohler, H1
Szu, SC1
Clarke, S1
Robbins, JB1
Wallick, S1
Yother, J1
Gray, BM1
Nahm, M1
Schroer, K1
Davie, J1
Baker, P1
Kearney, J1
Barletta, R1
Mold, C2
Nakayama, S1
Holzer, TJ1
Gewurz, H1
Du Clos, TW2
Limpanasithikul, W1
Ray, S1
Fischer, RT2
Longo, DL2
Kenny, JJ2
Lim, PL2
Choy, WF2
Chan, ST1
Leung, DT1
Ng, SS1
Nicoletti, C2
Yang, X1
Cerny, J1
Guo, WX1
Burger, AM1
Sieckmann, DG1
Ekdahl, K1
Braconier, JH1
Svanborg, C1
Trolle, S1
Chachaty, E1
Kassis-Chikhani, N1
Wang, C1
Fattal, E1
Couvreur, P1
Alonso, J1
Andremont, A1
Gosink, KK1
Mann, ER1
Guglielmo, C1
Masure, HR1
Park, MK1
Nahm, MH1
Rodic-Polic, B1
Crain, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The SILVA Study: Survival in an International Phase III Prospective Randomized LD Small Cell Lung Cancer Vaccination Study With Adjuvant BEC2 and BCG[NCT00037713]Phase 3515 participants (Actual)Interventional1998-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

4 reviews available for phosphorylcholine and Pneumococcal Infections

ArticleYear
Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Microbiology and immunology, 2017, Volume: 61, Issue:6

    Topics: Adjuvants, Immunologic; Administration, Intranasal; Animals; Antibodies, Bacterial; Antigens, Bacter

2017
Structure-Function Relationships of C-Reactive Protein in Bacterial Infection.
    Frontiers in immunology, 2019, Volume: 10

    Topics: Animals; Bacterial Infections; C-Reactive Protein; Host-Pathogen Interactions; Humans; Phosphorylcho

2019
Review of phosphocholine substituents on bacterial pathogen glycans: synthesis, structures and interactions with host proteins.
    Molecular immunology, 2013, Volume: 56, Issue:4

    Topics: C-Reactive Protein; Host-Pathogen Interactions; Humans; Molecular Structure; Phosphorylcholine; Pneu

2013
Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage.
    Journal of molecular medicine (Berlin, Germany), 2010, Volume: 88, Issue:2

    Topics: Humans; Immunity, Innate; Organ Specificity; Phosphorylcholine; Platelet Membrane Glycoproteins; Pne

2010

Other Studies

40 other studies available for phosphorylcholine and Pneumococcal Infections

ArticleYear
Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
    Vaccine, 2020, 01-16, Volume: 38, Issue:3

    Topics: Administration, Intranasal; Animals; Female; Immunity; Immunization, Secondary; Mice; Mice, Inbred B

2020
The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation.
    The Journal of experimental medicine, 2013, May-06, Volume: 210, Issue:5

    Topics: Amino Acid Sequence; Animals; Antibodies; Antibody Formation; Complementarity Determining Regions; C

2013
A C-terminal truncated mutation of licC attenuates the virulence of Streptococcus pneumoniae.
    Research in microbiology, 2014, Volume: 165, Issue:8

    Topics: Animals; Bacterial Adhesion; Cell Line; Choline-Phosphate Cytidylyltransferase; Disease Models, Anim

2014
Human L-ficolin recognizes phosphocholine moieties of pneumococcal teichoic acid.
    Journal of immunology (Baltimore, Md. : 1950), 2014, Dec-01, Volume: 193, Issue:11

    Topics: Acetylation; Cell Wall; Complement Activation; Complement C3b; Complement C4b; Fibrinogen; Ficolins;

2014
Pleiotropic effects of cell wall amidase LytA on Streptococcus pneumoniae sensitivity to the host immune response.
    Infection and immunity, 2015, Volume: 83, Issue:2

    Topics: Animals; Bacterial Capsules; Bacterial Proteins; Cell Wall; Complement Activation; Complement C3; Co

2015
Impact of the glpQ2 gene on virulence in a Streptococcus pneumoniae serotype 19A sequence type 320 strain.
    Infection and immunity, 2015, Volume: 83, Issue:2

    Topics: Amino Acid Sequence; Animals; Autolysis; Bacterial Adhesion; Bacterial Proteins; Cell Line; Epitheli

2015
C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms.
    Infection and immunity, 2015, Volume: 83, Issue:5

    Topics: Animals; Bacterial Load; C-Reactive Protein; Disease Models, Animal; Male; Mice, Inbred C57BL; Mutan

2015
Micelle-Triggered β-Hairpin to α-Helix Transition in a 14-Residue Peptide from a Choline-Binding Repeat of the Pneumococcal Autolysin LytA.
    Chemistry (Weinheim an der Bergstrasse, Germany), 2015, May-26, Volume: 21, Issue:22

    Topics: Amino Acid Sequence; Bacterial Proteins; Binding Sites; Choline; Circular Dichroism; Humans; Micelle

2015
Bacterial exploitation of phosphorylcholine mimicry suppresses inflammation to promote airway infection.
    The Journal of clinical investigation, 2015, Oct-01, Volume: 125, Issue:10

    Topics: Animals; Bacterial Proteins; Carrier Proteins; Carrier State; Cell Wall; Haemophilus Infections; Hae

2015
Modular Architecture and Unique Teichoic Acid Recognition Features of Choline-Binding Protein L (CbpL) Contributing to Pneumococcal Pathogenesis.
    Scientific reports, 2016, 12-05, Volume: 6

    Topics: Animals; Binding Sites; Calcium; Carrier Proteins; Cell Wall; Choline; Crystallography, X-Ray; Femal

2016
Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
    Vaccine, 2011, Aug-05, Volume: 29, Issue:34

    Topics: Administration, Intranasal; Administration, Mucosal; Animals; Antibodies, Bacterial; Bacterial Vacci

2011
The phosphocholine-binding pocket on C-reactive protein is necessary for initial protection of mice against pneumococcal infection.
    The Journal of biological chemistry, 2012, Dec-14, Volume: 287, Issue:51

    Topics: Animals; Bacteremia; Binding Sites; C-Reactive Protein; CHO Cells; Cricetinae; Humans; Male; Mice; M

2012
Regulating the isotypic and idiotypic profile of an anti-PC antibody response: lessons from peptide mimics.
    Molecular immunology, 2002, Volume: 39, Issue:5-6

    Topics: Amino Acid Sequence; Animals; Antibodies, Bacterial; Female; Immunization; Immunoglobulin G; Immunog

2002
Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection.
    European journal of immunology, 2005, Volume: 35, Issue:10

    Topics: Animals; Cell Adhesion Molecules; Fluorescent Antibody Technique; Immunoglobulin M; Lectins, C-Type;

2005
Capsule does not block antibody binding to PspA, a surface virulence protein of Streptococcus pneumoniae.
    Microbial pathogenesis, 2006, Volume: 40, Issue:5

    Topics: Antibodies, Bacterial; Bacterial Capsules; Bacterial Proteins; Fluorescent Antibody Technique, Indir

2006
Platelet-activating factor receptor and innate immunity: uptake of gram-positive bacterial cell wall into host cells and cell-specific pathophysiology.
    Journal of immunology (Baltimore, Md. : 1950), 2006, Nov-01, Volume: 177, Issue:9

    Topics: Animals; Cell Wall; Endothelium, Vascular; Gram-Positive Bacteria; Immunity, Innate; Mice; Mice, Mut

2006
The effects of idiotype on the ability of IgG1 anti-phosphorylcholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.
    European journal of immunology, 1984, Volume: 14, Issue:11

    Topics: Animals; Antibodies, Anti-Idiotypic; Choline; Immunization, Passive; Immunoglobulin G; Immunoglobuli

1984
The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.
    The Journal of molecular and cellular immunology : JMCI, 1984, Volume: 1, Issue:5

    Topics: Animals; Immunoglobulin G; Immunoglobulin Isotypes; Mice; Mice, Inbred CBA; Phosphorylcholine; Pneum

1984
Blood clearance by anti-phosphocholine antibodies as a mechanism of protection in experimental pneumococcal bacteremia.
    Journal of immunology (Baltimore, Md. : 1950), 1984, Volume: 133, Issue:6

    Topics: Animals; Antibodies, Bacterial; Blood Bactericidal Activity; Choline; Dose-Response Relationship, Im

1984
Monoclonal idiotope vaccine against Streptococcus pneumoniae infection.
    Science (New York, N.Y.), 1984, Dec-14, Volume: 226, Issue:4680

    Topics: Animals; Antibodies, Monoclonal; Bacterial Vaccines; Immunoglobulin Idiotypes; Mice; Mice, Inbred BA

1984
Protection against pneumococcal infection in mice conferred by phosphocholine-binding antibodies: specificity of the phosphocholine binding and relation to several types.
    Infection and immunity, 1983, Volume: 39, Issue:2

    Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibody Specificity; Chemical Phenomena; Chem

1983
Resistance to Streptococcus pneumoniae is induced by a phosphocholine-protein conjugate.
    Journal of immunology (Baltimore, Md. : 1950), 1983, Volume: 130, Issue:6

    Topics: Animals; Antigens; Antigens, Bacterial; Cell Wall; Choline; Hemocyanins; Immunity, Active; Immunoglo

1983
Protection of mice from infection with Streptococcus pneumoniae by anti-phosphocholine antibody.
    Infection and immunity, 1982, Volume: 36, Issue:1

    Topics: Animals; Antibodies, Bacterial; Antibodies, Monoclonal; Antigen-Antibody Reactions; Choline; Female;

1982
Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae.
    The Journal of experimental medicine, 1982, Oct-01, Volume: 156, Issue:4

    Topics: Animals; Antibodies, Monoclonal; Choline; Immunoglobulin Idiotypes; Immunoglobulin M; Male; Mice; Mi

1982
Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.
    The Journal of experimental medicine, 1981, Mar-01, Volume: 153, Issue:3

    Topics: Animals; Antibodies; Antibody Formation; Antibody Specificity; Choline; Crosses, Genetic; Female; Hy

1981
C-reactive protein is protective against Streptococcus pneumoniae infection in mice.
    The Journal of experimental medicine, 1981, Nov-01, Volume: 154, Issue:5

    Topics: Animals; Animals, Newborn; Antigens; C-Reactive Protein; Female; Humans; Immune Tolerance; Mice; Mic

1981
Cross-reactive antibodies have both protective and pathogenic potential.
    Journal of immunology (Baltimore, Md. : 1950), 1995, Jul-15, Volume: 155, Issue:2

    Topics: Amino Acid Sequence; Animals; Antibodies, Bispecific; Base Sequence; Female; Hemocyanins; Immunoglob

1995
A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. Comparison of the 6-O-phosphocholine hydroxyhexanoate-conjugate with other phosphocholine-containing vaccines.
    Journal of immunology (Baltimore, Md. : 1950), 1995, Apr-01, Volume: 154, Issue:7

    Topics: Animals; Antigens; Azo Compounds; Caproates; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Hemo

1995
Transgene-encoded antiphosphorylcholine (T15+) antibodies protect CBA/N (xid) mice against infection with Streptococcus pneumoniae but not Trichinella spiralis.
    Infection and immunity, 1994, Volume: 62, Issue:5

    Topics: Animals; Antibodies; Female; Immunization; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Mice, Transg

1994
Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae.
    Journal of immunology (Baltimore, Md. : 1950), 1993, Jan-15, Volume: 150, Issue:2

    Topics: Aging; Animals; Antibodies, Bacterial; Antibodies, Monoclonal; Antibody Affinity; Antigens, Bacteria

1993
Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen.
    Experimental and molecular pathology, 1995, Volume: 62, Issue:2

    Topics: Aging; Animals; Animals, Newborn; Antibodies, Bacterial; Antibodies, Monoclonal; Antigen-Antibody Re

1995
Sequence changes at the V-D junction of the VH1 heavy chain of anti-phosphocholine antibodies alter binding to and protection against Streptococcus pneumoniae.
    International immunology, 1997, Volume: 9, Issue:5

    Topics: Amino Acid Sequence; Animals; Antibodies, Antiphospholipid; Antibody Affinity; Bacterial Adhesion; B

1997
Impaired antibody response to pneumococcal capsular polysaccharides and phosphorylcholine in adult patients with a history of bacteremic pneumococcal infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1997, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Bacterial; Bacteremia; Bacterial Vaccines; C

1997
Phase variation in colony opacity by Streptococcus pneumoniae.
    Microbial drug resistance (Larchmont, N.Y.), 1998,Summer, Volume: 4, Issue:2

    Topics: Animals; Bacterial Capsules; Choline; Flow Cytometry; Fluorescent Antibody Technique; Humans; Mice;

1998
Intranasal immunization with protein-linked phosphorylcholine protects mice against a lethal intranasal challenge with streptococcus pneumoniae.
    Vaccine, 2000, Jul-01, Volume: 18, Issue:26

    Topics: Administration, Intranasal; Animals; Female; Immunity, Mucosal; Immunization; Immunoglobulin A; Immu

2000
Role of novel choline binding proteins in virulence of Streptococcus pneumoniae.
    Infection and immunity, 2000, Volume: 68, Issue:10

    Topics: Animals; Bacterial Adhesion; Bacterial Proteins; Carrier Proteins; Cells, Cultured; Cloning, Molecul

2000
Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.
    Infection and immunity, 2000, Volume: 68, Issue:10

    Topics: Amino Acid Sequence; Animals; Antibodies, Anti-Idiotypic; Antibodies, Monoclonal; Cattle; Cross Reac

2000
Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors.
    Journal of immunology (Baltimore, Md. : 1950), 2002, Jun-15, Volume: 168, Issue:12

    Topics: Animals; Antibodies, Bacterial; C-Reactive Protein; Complement Pathway, Classical; Complement System

2002
Mouse antibody to phosphocholine can protect mice from infection with mouse-virulent human isolates of Streptococcus pneumoniae.
    Infection and immunity, 1992, Volume: 60, Issue:5

    Topics: Animals; Antibodies, Monoclonal; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Phosph

1992
A thymus-independent (type 1) phosphorylcholine antigen isolated from Trichinella spiralis protects mice against pneumococcal infection.
    Immunology, 1990, Volume: 69, Issue:3

    Topics: Animals; Antibodies, Helminth; Antigens, Helminth; Choline; Immunization; Mice; Mice, Inbred CBA; Ph

1990